Innovation Pharmaceuticals Inc (IPIX)

[roiresearch]

Big headlines with little price movement are a conundrum, or are they. At least with the annual report being filed yesterday, we can see there really haven't been that many shares issued since June 30th.

June 30th count: 328,317,492
September 10th count: 343,579,992

One timeframe missing in today's PR was the peer print being made available in September and replaced with the ambiguous statement of RBL nearing completion that we saw back on Aug 4th (it's in the PR heading)

Now that isn't the fault of IPIX because even GMU was anticipating being done with Brilacidin testing by late August.
https://www.eurekalert.org/pub_releases/2020-06/gmu-nsa060520.php

So things change. It was hinted that the RBL was curious to see the results of combining Remesdivir with Brilacidin in the July 20th PR. Seems like it made for great in vitro results, but we really need to get out of the pre-clinical data for Brilacidin. The person on twitter pretty much summed up all the great preclinical / in vitro data as saying Brilacidin is just another candidate.

We need to get into human trials. The annual report makes it seem as if IPIX knows the cost of the B human trial already, yet has not said anything as to whether they filed a Pre-IND or will jump straight into an IND. If we look at an example, look at ABIO's PR history. Pre-IND happens almost 1 month from being able to complete the IND (if all information is complete and FDA is satisfied) and then it's possibly another 30 days till trials can start.

The annual report hinted that because of the competitive field for Covid clinical trials, we can't be assured as to when our trial can/will be copmleted.

There is just so much value that could be added to this stock by bringing in a decent IR firm to handle these requests. Most of us (i assume) have been through the ringer before and know what basic questions wall street is looking for to give confidence in IPIX

ok, great headline today. wish there was a concrete timeframe given. stock gave back all it's gains which is a let down. if there is no dilution, it must be the flippers keeping the price down. The short position is really not that significant that has been posted before. imho of course.... or jmo....